Skip to main content
Feb 5-7, 2027
Miami
Register
Program
Agenda
CE Information
Get to Know LL&M Winter Symposium
Faculty
Hotel & Travel
Pricing
Exhibitors & Sponsors
Press Information
The Official Meeting of
Oncology Learning Network
Agenda
Agenda
February 5-7, 2027
Register
February 5-7, 2027
Scroll previous
Friday
February 5
Saturday
February 6
Sunday
February 7
Scroll next
Friday February 05, 2027
8:30 AM – 10:15 AM
The Evolving Leukemia Landscape: Precision Medicine Takes Hold in AML
Room
King Ballroom 3
8:30 AM – 8:40 AM
Welcome
8:40 AM – 9:00 AM
Fit or Not: AML Induction Decisions for the Year Ahead
9:00 AM – 9:20 AM
Navigating FLT3 Inhibitors: What's Next in AML?
9:20 AM – 9:40 AM
AML MRD in 2027: How to Use the New ELN Guidelines
9:40 AM – 9:50 AM
Q&A Panel
9:50 AM – 10:15 AM
Making It Matter: Translating Data Into Practice
10:20 AM – 11:20 AM
Innovation Theater (non-CME)
Room
Garden Room
11:20 AM – 1:20 PM
The Evolving Leukemia Landscape: Extending Survival and Reducing Burden in MDS, MPN & ALL
Room
King Ballroom 3
11:20 AM – 11:40 AM
MDS in 2027: Treatment Strategies from Supportive Care to Transplant
11:40 AM – 12:00 PM
Myeloproliferative Neoplasms Enter a New Therapeutic Era
12:00 PM – 12:20 PM
Can Older Patients with ALL Move Toward Chemo-Free Care?
12:20 PM – 12:30 PM
Q&A Panel
12:30 PM – 1:20 PM
Navigating the Gray Zones: A Case-Based Panel Discussion in Leukemia
1:25 PM – 2:25 PM
Innovation Theater (non-CME)
Room
Garden Room
2:25 PM – 2:55 PM
Exhibit Hall
Room
King Ballroom 1-2
2:55 PM – 4:55 PM
The Evolving Lymphoma Landscape: Sequencing Novel Agents Across Indolent Disease and Special Populations
Room
King Ballroom 3
2:55 PM – 3:15 PM
Follicular Lymphoma in 2027: Sequencing Bispecifics, CAR-T, and the Next Wave of Novel Agents
3:15 PM – 3:35 PM
Reflecting on 2026 and Charting a New Course for Older, Unfit Patients with DLBCL
3:35 PM – 3:55 PM
From Afterthought to Frontier: Sequencing BTK Inhibitors, Bispecifics, and Cellular Therapy in Marginal Zone Lymphoma
3:55 PM – 4:05 PM
Q&A Panel
4:05 PM – 4:55 PM
Translating Evidence Into Action: A Case Discussion Panel in Lymphoma
5:00 PM – 6:00 PM
Innovation Theater (non-CME)
Room
Garden Room
6:00 PM – 6:45 PM
Exhibit Hall Reception
Room
King Ballroom 1-2
Saturday February 06, 2027
8:30 AM – 10:10 AM
The Evolving Lymphoma Landscape: Retiring Old Standards, Writing New Ones
Room
King Ballroom 3
8:30 AM – 8:35 AM
Welcome
8:35 AM – 8:55 AM
Hodgkin Lymphoma's New Standard: Immunotherapy Moves to the Frontline
8:55 AM – 9:15 AM
Mantle Cell Lymphoma Turns the Page on Transplant and Chemotherapy
9:15 AM – 9:35 AM
Rewriting the DLBCL Playbook for the Year Ahead
9:35 AM – 9:45 AM
Q&A Panel
9:45 AM – 10:10 AM
Making It Matter: Translating Data Into Practice
10:15 AM – 11:15 AM
Innovation Theater (non-CME)
Room
Garden Room
11:15 AM – 1:15 PM
The Evolving CLL Landscape: The Chemo-Free Frontline Comes of Age
Room
King Ballroom 3
11:15 AM – 11:35 AM
The Anti-CD20 Question in BCL2i-Based Fixed-Duration CLL Therapy: New Evidence from 2026
11:35 AM – 11:55 AM
Continuous Therapy in CLL: Weighing the Newest Evidence
11:55 AM – 12:15 PM
New Approval: Sonrotoclax, the Next-Gen BCL2 Inhibitor in CLL
12:15 PM – 12:25 PM
Q&A Panel
12:25 PM – 1:15 PM
Clinical Crossroads: A Case Discussion Panel in CLL
1:20 PM – 2:20 PM
Innovation Theater (non-CME)
Room
Garden Room
2:20 PM – 2:50 PM
Exhibit Hall
Room
King Ballroom 1-2
2:50 PM – 4:25 PM
The Evolving CLL Landscape: The Next Wave of Therapy for Relapsed and High-Risk Disease
Room
King Ballroom 3
2:50 PM – 3:10 PM
Bispecific Antibodies and CAR-T in CLL: Positioning Two Emerging Immunotherapies
3:10 PM – 3:30 PM
Richter Transformation in 2027: Any Updates?
3:30 PM – 3:50 PM
BTK Degraders in CLL: Where Do We Currently Stand?
3:50 PM – 4:00 PM
Q&A Panel
4:00 PM – 4:25 PM
Making It Matter: Translating Data Into Practice
4:30 PM – 5:30 PM
Innovation Theater (non-CME)
Room
Garden Room
5:45 PM – 7:15 PM
Outdoor Welcome Reception
Room
Cascata Pool
Sunday February 07, 2027
8:30 AM – 8:35 AM
Welcome
Room
King Ballroom 3
8:35 AM – 9:35 AM
Specialty Session
Room
King Ballroom 3
9:40 AM – 10:40 AM
Innovation Theater (non-CME)
Room
Garden Room
10:40 AM – 11:10 AM
Exhibit Hall
Room
King Ballroom 1-2
11:10 AM – 12:45 PM
The Evolving Myeloma Landscape: Precision Monitoring from Smoldering Disease to MRD
Room
King Ballroom 3
11:10 AM – 11:30 AM
Smoldering Myeloma in 2027: Latest Clinical Updates on Risk Stratification and Early Intervention
11:30 AM – 11:50 AM
Beyond the Bone Marrow: Liquid Biopsies and Advanced Imaging for Disease Monitoring
11:50 AM – 12:10 PM
MRD in 2027: From Clinical Trial Endpoint to Clinical Decision Tool
12:10 PM – 12:20 PM
Q&A Panel
12:20 PM – 12:45 PM
Making It Matter: Translating Data Into Practice
12:50 PM – 1:50 PM
Innovation Theater (non-CME)
Room
Garden Room
1:50 PM – 3:50 PM
The Evolving Myeloma Landscape: Expanding the Cellular and Immunotherapy Toolbox
Room
King Ballroom 3
1:50 PM – 2:10 PM
Bispecific and Trispecific Antibodies: Expanding the Immunotherapy Toolbox in Myeloma
2:10 PM – 2:30 PM
CAR-T Cell Therapy in 2027: Optimizing Outcomes Across the Disease Continuum
2:30 PM – 2:50 PM
Future in cellular therapy: non BCMA targets and In Vivo CAR-T: Engineering Cellular Therapy Without Manufacturing
2:50 PM – 3:00 PM
Q&A Panel
3:00 PM – 3:50 PM
From Trial to Treatment: A Case Discussion Panel in Myeloma
Back to top
